Inventor
YU DE-CHAO
US21 patents
⚠️ This page may combine multiple inventors who share the name “YU DE-CHAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELL GENESYS INC
16 patentsUS6692736B2Feb 17, 2004
Cell-specific adenovirus vectors comprising an internal ribosome entry site
CELL GENESYS INC129 citations97
US6436394B1Aug 20, 2002
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
CELL GENESYS INC90 citations97
US6432700B1Aug 13, 2002
Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
CELL GENESYS INC65 citations96
US7048920B2May 23, 2006
Recombinant oncolytic adenovirus for human melanoma
CELL GENESYS INC54 citations95
US7364727B2Apr 29, 2008
Metastatic colon cancer specific promoter and uses thereof
CELL GENESYS INC19 citations92
US6991935B2Jan 31, 2006
Target cell-specific adenoviral vectors containing E3 and methods of use thereof
CELL GENESYS INC16 citations92
US6916918B2Jul 12, 2005
Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
CELL GENESYS INC32 citations92
US6911200B2Jun 28, 2005
Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation
CELL GENESYS INC30 citations92
US6900049B2May 31, 2005
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
CELL GENESYS INC26 citations92
US6852528B2Feb 8, 2005
Human and mouse uroplakin II gene transcriptional regulatory elements
CELL GENESYS INC26 citations92
US7074618B2Jul 11, 2006
Adenoviral E1A/E1B complementing cell line
CELL GENESYS INC14 citations90
US7575919B2Aug 18, 2009
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
CELL GENESYS INC11 citations84
US7319033B2Jan 15, 2008
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
CELL GENESYS INC9 citations84
US6406861B1Jun 18, 2002
Methods of enhancing effectiveness of therapeutic viral immunogenic agent administration
CELL GENESYS INC12 citations74
US7276233B2Oct 2, 2007
Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy
CELL GENESYS INC2 citations63
US7371570B2May 13, 2008
Cell-specific adenovirus vector comprising EBV-specific promoter
CELL GENESYS INC4 citations61
CALYDON INC
3 patentsUS6495130B1Dec 17, 2002
Target cell-specific adenoviral vectors containing E3 and methods of use thereof
CALYDON INC54 citations96
US6197293B1Mar 6, 2001
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
CALYDON INC54 citations95
US6051417AApr 18, 2000
Prostate cancer drug screening using hKLK2 enhancer
CALYDON INC7 citations72